The global Ischemic Hepatitis Treatment Market was valued at US$ 5 billion in FY 2021 and is expected to rise 5.6% year on year to US$ 5.3 billion in 2022. During the projection period of 2022 to 2032, the market is expected to grow at a 5.2% value CAGR to reach US$ 8.8 billion. Every year, ischemic hepatitis, commonly known as shock liver, affects 0.18 to 0.50 percent of inpatient admissions....